David Clendenin, | |
1033 Dr Martin Luther King Jr St N, Suite 108, St Petersburg, FL 33701-1547 | |
(727) 456-3288 | |
(727) 456-3289 |
Full Name | David Clendenin |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 23 Years |
Location | 1033 Dr Martin Luther King Jr St N, St Petersburg, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306943493 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | ME91268 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tampa General Hospital | Tampa, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Greater Florida Anesthesiologists Llc | 3173711017 | 455 |
Gulf-to-bay Anesthesiology Associates Llc | 5092628156 | 363 |
Capital Anesthesia Solutions Of Florida Ii, Llc | 7911323720 | 212 |
News Archive
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its first quarter 2010 financial results.
Duke University Medical Center researchers believe their findings could help physicians identify patients at risk of suffering mental decline after heart surgery and raises the possibility that these patients could be treated with drugs that are known to dampen the inflammatory response.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
The Scripps Research Institute and OPKO Health, Inc. today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 9 days ago
Entity Name | Gulf-to-bay Anesthesiology Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720039746 PECOS PAC ID: 5092628156 Enrollment ID: O20031106000250 |
News Archive
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its first quarter 2010 financial results.
Duke University Medical Center researchers believe their findings could help physicians identify patients at risk of suffering mental decline after heart surgery and raises the possibility that these patients could be treated with drugs that are known to dampen the inflammatory response.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
The Scripps Research Institute and OPKO Health, Inc. today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 9 days ago
Entity Name | Greater Florida Anesthesiologists Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528630795 PECOS PAC ID: 3173711017 Enrollment ID: O20101220000829 |
News Archive
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its first quarter 2010 financial results.
Duke University Medical Center researchers believe their findings could help physicians identify patients at risk of suffering mental decline after heart surgery and raises the possibility that these patients could be treated with drugs that are known to dampen the inflammatory response.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
The Scripps Research Institute and OPKO Health, Inc. today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 9 days ago
Entity Name | Fleming Island Anesthesia Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487945895 PECOS PAC ID: 6002084860 Enrollment ID: O20110721000345 |
News Archive
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its first quarter 2010 financial results.
Duke University Medical Center researchers believe their findings could help physicians identify patients at risk of suffering mental decline after heart surgery and raises the possibility that these patients could be treated with drugs that are known to dampen the inflammatory response.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
The Scripps Research Institute and OPKO Health, Inc. today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 9 days ago
Entity Name | Sunbelt Anesthesia Services, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205172079 PECOS PAC ID: 9436392438 Enrollment ID: O20130823000172 |
News Archive
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its first quarter 2010 financial results.
Duke University Medical Center researchers believe their findings could help physicians identify patients at risk of suffering mental decline after heart surgery and raises the possibility that these patients could be treated with drugs that are known to dampen the inflammatory response.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
The Scripps Research Institute and OPKO Health, Inc. today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 9 days ago
Entity Name | Anesthesia Dynamics Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073001012 PECOS PAC ID: 3779832530 Enrollment ID: O20190820001117 |
News Archive
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its first quarter 2010 financial results.
Duke University Medical Center researchers believe their findings could help physicians identify patients at risk of suffering mental decline after heart surgery and raises the possibility that these patients could be treated with drugs that are known to dampen the inflammatory response.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
The Scripps Research Institute and OPKO Health, Inc. today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 9 days ago
Entity Name | Capital Anesthesia Solutions Of Florida Ii, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891318481 PECOS PAC ID: 7911323720 Enrollment ID: O20200811002165 |
News Archive
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its first quarter 2010 financial results.
Duke University Medical Center researchers believe their findings could help physicians identify patients at risk of suffering mental decline after heart surgery and raises the possibility that these patients could be treated with drugs that are known to dampen the inflammatory response.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
The Scripps Research Institute and OPKO Health, Inc. today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
David Clendenin, 1033 Dr Martin Luther King Jr St N, Suite 108, St Petersburg, FL 33701-1547 Ph: (727) 456-3288 | David Clendenin, 1033 Dr Martin Luther King Jr St N, Suite 108, St Petersburg, FL 33701-1547 Ph: (727) 456-3288 |
News Archive
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its first quarter 2010 financial results.
Duke University Medical Center researchers believe their findings could help physicians identify patients at risk of suffering mental decline after heart surgery and raises the possibility that these patients could be treated with drugs that are known to dampen the inflammatory response.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
The Scripps Research Institute and OPKO Health, Inc. today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 9 days ago
Geoffrey Boyajian, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12225 28th St N, Ste A, St Petersburg, FL 33716 Phone: 727-823-2188 Fax: 727-828-0723 | |
Dr. Todd Kenneth Letzring, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1200 7th Ave N, St Petersburg, FL 33705 Phone: 727-825-1053 | |
Jacqueline Biance, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 701 6th St S, St Petersburg, FL 33701 Phone: 727-823-1234 | |
Thor William Van Diver, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 701 6th St S, St Petersburg, FL 33701 Phone: 727-823-2188 Fax: 727-828-0723 | |
Shivani M Patel, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 501 6th St S, St Petersburg, FL 33701 Phone: 727-898-7451 | |
Joseph Martin Vulgamore, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1033 Dr Martin Luther King Jr St N, Suite 108, St Petersburg, FL 33701 Phone: 727-456-3288 Fax: 727-456-3289 | |
Cindy K Hernandez, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 501 6th Ave S, St Petersburg, FL 33701 Phone: 727-767-3583 Fax: 727-767-8429 |